IAVI C004/DHO-614
Status:Completed
Phase:I
Principal Investigator(s):
Objective:Evaluation of local and systemic reactogenicity following serial administration of ADVAX.
Prevention Option(s):HIV Vaccine
Study Design:
Arms and Assigned Interventions
DescriptionADVAX vaccine, ADVAX e/g + ADVAX p/n-t, by Ichor TriGrid™ in vivo electroporation.
Mode of Delivery
ARMs
Official Code:
IAVI C004/DHO-614
Trial Sponsors:
Aaron Diamond AIDS Research Center, IAVI, University of Rochester
Start Date
End Date
none
none
Enrollment:40
Age range:
↔
any
Population: